Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barnaby Flower

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Open Forum Infectious Diseases|August 2, 2021
High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis With 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH StudyBarnaby Flower, Leanne McCabe, Chau Le Ngoc, et al.
Elife|January 9, 2023
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot studyBarnaby Flower, Le Manh Hung, Leanne Mccabe, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission updateGraham S Cooke, Barnaby Flower, Evan Cunningham, et al.
BMJ (Clinical Research Ed.)|March 3, 2021
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy studyMaya Moshe, Anna Daunt, Barnaby Flower, et al.
Journal of Virological Methods|January 25, 2022
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utilityCarolina Rosadas, Maryam Khan, Eleanor Parker, et al.
Lancet (London, England)|May 10, 2025
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trialGraham S Cooke, Le Manh Hung, Barnaby Flower, et al.
Thorax|August 16, 2020
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence surveyBarnaby Flower, Jonathan C Brown, Bryony Simmons, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Open Forum Infectious Diseases|August 2, 2021
High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis With 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH StudyBarnaby Flower, Leanne McCabe, Chau Le Ngoc, et al.
Elife|January 9, 2023
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot studyBarnaby Flower, Le Manh Hung, Leanne Mccabe, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission updateGraham S Cooke, Barnaby Flower, Evan Cunningham, et al.
BMJ (Clinical Research Ed.)|March 3, 2021
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy studyMaya Moshe, Anna Daunt, Barnaby Flower, et al.
Journal of Virological Methods|January 25, 2022
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utilityCarolina Rosadas, Maryam Khan, Eleanor Parker, et al.
Lancet (London, England)|May 10, 2025
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trialGraham S Cooke, Le Manh Hung, Barnaby Flower, et al.
Thorax|August 16, 2020
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence surveyBarnaby Flower, Jonathan C Brown, Bryony Simmons, et al.
Pageof 2